Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash-to-Debt No Debt
MASI's Cash-to-Debt is ranked higher than
89% of the 205 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.74 vs. MASI: No Debt )
Ranked among companies with meaningful Cash-to-Debt only.
MASI' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.49  Med: 280.38 Max: No Debt
Current: No Debt
0.49
No Debt
Equity-to-Asset 0.81
MASI's Equity-to-Asset is ranked higher than
60% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. MASI: 0.81 )
Ranked among companies with meaningful Equity-to-Asset only.
MASI' s Equity-to-Asset Range Over the Past 10 Years
Min: -1.01  Med: 0.73 Max: 0.81
Current: 0.81
-1.01
0.81
Interest Coverage No Debt
MASI's Interest Coverage is ranked higher than
91% of the 137 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 63.92 vs. MASI: No Debt )
Ranked among companies with meaningful Interest Coverage only.
MASI' s Interest Coverage Range Over the Past 10 Years
Min: 94.75  Med: 5548.18 Max: No Debt
Current: No Debt
94.75
No Debt
Piotroski F-Score: 6
Altman Z-Score: 20.23
Beneish M-Score: -2.30
WACC vs ROIC
11.43%
34.55%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 25.23
MASI's Operating Margin % is ranked higher than
88% of the 201 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.41 vs. MASI: 25.23 )
Ranked among companies with meaningful Operating Margin % only.
MASI' s Operating Margin % Range Over the Past 10 Years
Min: 15.88  Med: 19.17 Max: 25.23
Current: 25.23
15.88
25.23
Net Margin % 15.99
MASI's Net Margin % is ranked higher than
79% of the 201 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.18 vs. MASI: 15.99 )
Ranked among companies with meaningful Net Margin % only.
MASI' s Net Margin % Range Over the Past 10 Years
Min: 10.4  Med: 13.87 Max: 43.28
Current: 15.99
10.4
43.28
ROE % 18.66
MASI's ROE % is ranked higher than
85% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.43 vs. MASI: 18.66 )
Ranked among companies with meaningful ROE % only.
MASI' s ROE % Range Over the Past 10 Years
Min: 17.28  Med: 22.79 Max: 71.96
Current: 18.66
17.28
71.96
ROA % 14.53
MASI's ROA % is ranked higher than
88% of the 206 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.85 vs. MASI: 14.53 )
Ranked among companies with meaningful ROA % only.
MASI' s ROA % Range Over the Past 10 Years
Min: 12.07  Med: 15.8 Max: 42.28
Current: 14.53
12.07
42.28
ROC (Joel Greenblatt) % 95.38
MASI's ROC (Joel Greenblatt) % is ranked higher than
89% of the 204 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.63 vs. MASI: 95.38 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
MASI' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 67.1  Med: 111.78 Max: 262.69
Current: 95.38
67.1
262.69
3-Year Revenue Growth Rate 10.60
MASI's 3-Year Revenue Growth Rate is ranked higher than
53% of the 170 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.10 vs. MASI: 10.60 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
MASI' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -19.3  Med: 12.2 Max: 30.3
Current: 10.6
-19.3
30.3
3-Year EBITDA Growth Rate 26.80
MASI's 3-Year EBITDA Growth Rate is ranked higher than
55% of the 155 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.00 vs. MASI: 26.80 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
MASI' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: 5.6 Max: 420.3
Current: 26.8
0
420.3
3-Year EPS without NRI Growth Rate 22.00
MASI's 3-Year EPS without NRI Growth Rate is ranked higher than
55% of the 155 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 12.90 vs. MASI: 22.00 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
MASI' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: 7.4 Max: 76.9
Current: 22
0
76.9
GuruFocus has detected 2 Warning Signs with Masimo Corp MASI.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» MASI's 30-Y Financials

Financials (Next Earnings Date: 2018-08-02)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2017

MASI Guru Trades in Q2 2017

Jim Simons 620,500 sh (+44.60%)
Paul Tudor Jones 4,771 sh (+44.58%)
Columbia Wanger 722,577 sh (+27.76%)
Jeremy Grantham 2,300 sh (unchged)
Caxton Associates 5,000 sh (unchged)
Chuck Royce 117,600 sh (unchged)
Mario Gabelli 130,000 sh (unchged)
Joel Greenblatt 11,744 sh (-0.31%)
» More
Q3 2017

MASI Guru Trades in Q3 2017

George Soros 2,700 sh (New)
Joel Greenblatt 62,657 sh (+433.52%)
Columbia Wanger 1,022,577 sh (+41.52%)
Jim Simons 683,400 sh (+10.14%)
Chuck Royce 124,600 sh (+5.95%)
Jeremy Grantham Sold Out
Paul Tudor Jones Sold Out
Mario Gabelli 125,000 sh (-3.85%)
Caxton Associates 4,400 sh (-12.00%)
» More
Q4 2017

MASI Guru Trades in Q4 2017

Pioneer Investments 4,381 sh (New)
John Hussman 25,000 sh (New)
Steven Cohen 684,025 sh (New)
Columbia Wanger 1,213,569 sh (+18.68%)
Caxton Associates 4,400 sh (unchged)
George Soros Sold Out
Joel Greenblatt Sold Out
Mario Gabelli 122,500 sh (-2.00%)
Chuck Royce 116,837 sh (-6.23%)
Jim Simons 552,100 sh (-19.21%)
» More
Q1 2018

MASI Guru Trades in Q1 2018

Joel Greenblatt 33,284 sh (New)
Paul Tudor Jones 3,271 sh (New)
Steven Cohen 1,381,945 sh (+102.03%)
John Hussman Sold Out
Caxton Associates Sold Out
Mario Gabelli 122,000 sh (-0.41%)
Pioneer Investments 4,128 sh (-5.77%)
Jim Simons 511,500 sh (-7.35%)
Chuck Royce 103,721 sh (-11.23%)
» More
» Details

Insider Trades

Latest Guru Trades with MASI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Mario Gabelli 2018-03-31 Reduce -0.41%$82.06 - $95.19 $ 102.3417%122,000
Joel Greenblatt 2018-03-31 New Buy0.04%$82.06 - $95.19 $ 102.3417%33,284
Mario Gabelli 2017-12-31 Reduce -2.00%$84.49 - $90.09 $ 102.3418%122,500
George Soros 2017-12-31 Sold Out 0.01%$84.49 - $90.09 $ 102.3418%0
Joel Greenblatt 2017-12-31 Sold Out 0.08%$84.49 - $90.09 $ 102.3418%0
Mario Gabelli 2017-09-30 Reduce -3.85%$81.79 - $98.77 $ 102.3416%125,000
Joel Greenblatt 2017-09-30 Add 433.52%0.07%$81.79 - $98.77 $ 102.3416%62,657
George Soros 2017-09-30 New Buy0.01%$81.79 - $98.77 $ 102.3416%2,700
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS: 339112    SIC: 3841
Compare:OCSE:GN, NAS:IART, OCSE:AMBU B, OSTO:EKTA B, NYSE:GMED, NYSE:PEN, NAS:LIVN, NZSE:FPH, LSE:CTEC, SZSE:002223, NAS:INGN, SZSE:300529, HKSE:01066, NAS:NUVA, NYSE:NVRO, XSWX:TECN, SZSE:300633, TSE:6849, TSE:8086, TSE:7575 » details
Traded in other countries:3M4.Germany,
Headquarter Location:USA
Masimo Corp is a medical technology company. The company develops, manufactures, and markets noninvasive monitoring technologies. Its product includes noninvasive blood constituent and brain and breath monitoring.

Masimo is an Irvine, California-based medical device business focusing on noninvasive patient monitoring. It began by developing superior signal processing algorithms to measure blood oxygenation levels through pulse oximetry and has expanded this expertise into a wide range of measurements and applications. The company generates revenue on a global basis, with the United States representing the largest market (68% of 2017 sales), followed by Europe, the Middle East and Africa (19%), Asia and Australia (10%), and North and South America excluding the U.S. (3%).

Top Ranked Articles about Masimo Corp

The Federal Reserve and Valuations Rising interest rates can offset corporate growth when it comes to corporate valuations
“In the field of monetary and credit policy, precautionary action to prevent inflationary excesses is bound to have some onerous effects--if it did not it would be ineffective and futile. Those who have the task of making such policy don’t expect you to applaud. The Federal Reserve, as one writer put it, after the recent increase in the discount rate, is in the position of the chaperone who has ordered the punch bowl removed just when the party was really warming up."[1] Read more...
Investor Expectations to Drive Momentum within CVB Financial, New Senior Investment Group, EXTRACTION O&G, Masimo, Timken Steel, and Commercial Vehicle Group — Discovering Underlying Factors of Influence
Report: Developing Opportunities within NewJersey Resources, Masimo, New Mountain Finance, Hess, Hologic, and UnitedHealth Group — Future Expectations, Projections Moving into 2018
Report: Developing Opportunities within Hess, Hologic, UnitedHealth Group, NewJersey Resources, Masimo, and New Mountain Finance — Future Expectations, Projections Moving into 2018
6 Negative Assets in Gurus' Portfolios DaVita, Masimo among companies with falling stock prices and returns
While gurus hold positions in these companies, the stock prices and returns continue to fall. These are the worst-performing stocks over the past three months with a long-term presence in more than four gurus’ portfolios. Read more...

Ratios

vs
industry
vs
history
PE Ratio 43.53
MASI's PE Ratio is ranked higher than
74% of the 125 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.70 vs. MASI: 43.53 )
Ranked among companies with meaningful PE Ratio only.
MASI' s PE Ratio Range Over the Past 10 Years
Min: 10.85  Med: 25.25 Max: 69.65
Current: 43.53
10.85
69.65
Forward PE Ratio 35.09
MASI's Forward PE Ratio is ranked lower than
88% of the 40 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 26.32 vs. MASI: 35.09 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 43.53
MASI's PE Ratio without NRI is ranked higher than
76% of the 123 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. MASI: 43.53 )
Ranked among companies with meaningful PE Ratio without NRI only.
MASI' s PE Ratio without NRI Range Over the Past 10 Years
Min: 10.85  Med: 25.25 Max: 69.65
Current: 43.53
10.85
69.65
Price-to-Owner-Earnings 225.38
MASI's Price-to-Owner-Earnings is ranked lower than
99.99% of the 83 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.92 vs. MASI: 225.38 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
MASI' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 8.96  Med: 29.69 Max: 226.86
Current: 225.38
8.96
226.86
PB Ratio 6.90
MASI's PB Ratio is ranked lower than
99.99% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.45 vs. MASI: 6.90 )
Ranked among companies with meaningful PB Ratio only.
MASI' s PB Ratio Range Over the Past 10 Years
Min: 3.41  Med: 6.22 Max: 15.19
Current: 6.9
3.41
15.19
PS Ratio 6.92
MASI's PS Ratio is ranked lower than
99.99% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.48 vs. MASI: 6.92 )
Ranked among companies with meaningful PS Ratio only.
MASI' s PS Ratio Range Over the Past 10 Years
Min: 1.77  Med: 3.65 Max: 8.08
Current: 6.92
1.77
8.08
Price-to-Free-Cash-Flow 86.49
MASI's Price-to-Free-Cash-Flow is ranked lower than
99.99% of the 74 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.61 vs. MASI: 86.49 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
MASI' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 8.39  Med: 29.22 Max: 2401.82
Current: 86.49
8.39
2401.82
Price-to-Operating-Cash-Flow 49.74
MASI's Price-to-Operating-Cash-Flow is ranked lower than
99.99% of the 94 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.15 vs. MASI: 49.74 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
MASI' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 7.89  Med: 21.47 Max: 92.05
Current: 49.74
7.89
92.05
EV-to-EBIT 23.65
MASI's EV-to-EBIT is ranked lower than
64% of the 121 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.93 vs. MASI: 23.65 )
Ranked among companies with meaningful EV-to-EBIT only.
MASI' s EV-to-EBIT Range Over the Past 10 Years
Min: 1.6  Med: 18.9 Max: 35.7
Current: 23.65
1.6
35.7
EV-to-EBITDA 21.52
MASI's EV-to-EBITDA is ranked lower than
73% of the 138 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.49 vs. MASI: 21.52 )
Ranked among companies with meaningful EV-to-EBITDA only.
MASI' s EV-to-EBITDA Range Over the Past 10 Years
Min: 1.6  Med: 17 Max: 33
Current: 21.52
1.6
33
EV-to-Revenue 5.97
MASI's EV-to-Revenue is ranked lower than
99.99% of the 199 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.57 vs. MASI: 5.97 )
Ranked among companies with meaningful EV-to-Revenue only.
MASI' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.3  Med: 3.8 Max: 8.6
Current: 5.97
1.3
8.6
PEG Ratio 2.14
MASI's PEG Ratio is ranked higher than
74% of the 69 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.70 vs. MASI: 2.14 )
Ranked among companies with meaningful PEG Ratio only.
MASI' s PEG Ratio Range Over the Past 10 Years
Min: 0.69  Med: 3.14 Max: 9.24
Current: 2.14
0.69
9.24
Shiller PE Ratio 53.43
MASI's Shiller PE Ratio is ranked lower than
54% of the 54 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 50.97 vs. MASI: 53.43 )
Ranked among companies with meaningful Shiller PE Ratio only.
MASI' s Shiller PE Ratio Range Over the Past 10 Years
Min: 20.24  Med: 43.92 Max: 62.65
Current: 53.43
20.24
62.65
Current Ratio 4.55
MASI's Current Ratio is ranked lower than
57% of the 200 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.57 vs. MASI: 4.55 )
Ranked among companies with meaningful Current Ratio only.
MASI' s Current Ratio Range Over the Past 10 Years
Min: 1.25  Med: 2.97 Max: 4.87
Current: 4.55
1.25
4.87
Quick Ratio 3.86
MASI's Quick Ratio is ranked lower than
55% of the 201 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.87 vs. MASI: 3.86 )
Ranked among companies with meaningful Quick Ratio only.
MASI' s Quick Ratio Range Over the Past 10 Years
Min: 0.99  Med: 2.44 Max: 4.34
Current: 3.86
0.99
4.34
Days Inventory 122.91
MASI's Days Inventory is ranked lower than
63% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 124.35 vs. MASI: 122.91 )
Ranked among companies with meaningful Days Inventory only.
MASI' s Days Inventory Range Over the Past 10 Years
Min: 100.9  Med: 108.25 Max: 122.91
Current: 122.91
100.9
122.91
Days Sales Outstanding 44.74
MASI's Days Sales Outstanding is ranked higher than
53% of the 165 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.97 vs. MASI: 44.74 )
Ranked among companies with meaningful Days Sales Outstanding only.
MASI' s Days Sales Outstanding Range Over the Past 10 Years
Min: 36.51  Med: 47.15 Max: 55.48
Current: 44.74
36.51
55.48
Days Payable 49.85
MASI's Days Payable is ranked lower than
99.99% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 54.66 vs. MASI: 49.85 )
Ranked among companies with meaningful Days Payable only.
MASI' s Days Payable Range Over the Past 10 Years
Min: 42.89  Med: 59.96 Max: 70.9
Current: 49.85
42.89
70.9

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio 0.50
MASI's 3-Year Average Share Buyback Ratio is ranked higher than
83% of the 143 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -5.00 vs. MASI: 0.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
MASI' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -79.8  Med: -0.7 Max: 4.3
Current: 0.5
-79.8
4.3

Valuation & Return

vs
industry
vs
history
Price-to-Net-Cash 28.43
MASI's Price-to-Net-Cash is ranked lower than
99.99% of the 49 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 13.15 vs. MASI: 28.43 )
Ranked among companies with meaningful Price-to-Net-Cash only.
MASI' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 13.79  Med: 38.44 Max: 2566
Current: 28.43
13.79
2566
Price-to-Net-Current-Asset-Value 12.82
MASI's Price-to-Net-Current-Asset-Value is ranked lower than
99.99% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.83 vs. MASI: 12.82 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
MASI' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 6.17  Med: 11.02 Max: 193.7
Current: 12.82
6.17
193.7
Price-to-Tangible-Book 7.39
MASI's Price-to-Tangible-Book is ranked lower than
99.99% of the 167 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.77 vs. MASI: 7.39 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
MASI' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 4.11  Med: 6.64 Max: 14.94
Current: 7.39
4.11
14.94
Price-to-Intrinsic-Value-Projected-FCF 2.61
MASI's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
81% of the 75 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.41 vs. MASI: 2.61 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
MASI' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 1.34  Med: 2.25 Max: 3.93
Current: 2.61
1.34
3.93
Price-to-Median-PS-Value 1.90
MASI's Price-to-Median-PS-Value is ranked lower than
99.99% of the 160 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.13 vs. MASI: 1.90 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
MASI' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.56  Med: 0.98 Max: 2.01
Current: 1.9
0.56
2.01
Price-to-Peter-Lynch-Fair-Value 1.97
MASI's Price-to-Peter-Lynch-Fair-Value is ranked higher than
64% of the 45 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.46 vs. MASI: 1.97 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
MASI' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.7  Med: 1.95 Max: 5.55
Current: 1.97
0.7
5.55
Price-to-Graham-Number 3.78
MASI's Price-to-Graham-Number is ranked lower than
91% of the 94 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.77 vs. MASI: 3.78 )
Ranked among companies with meaningful Price-to-Graham-Number only.
MASI' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.8  Med: 2.82 Max: 6.61
Current: 3.78
1.8
6.61
Earnings Yield (Greenblatt) % 4.26
MASI's Earnings Yield (Greenblatt) % is ranked higher than
63% of the 207 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.40 vs. MASI: 4.26 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
MASI' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 2.8  Med: 5.3 Max: 60.6
Current: 4.26
2.8
60.6
Forward Rate of Return (Yacktman) % 22.08
MASI's Forward Rate of Return (Yacktman) % is ranked higher than
91% of the 101 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.66 vs. MASI: 22.08 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
MASI' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -30.4  Med: 8.5 Max: 22.5
Current: 22.08
-30.4
22.5

More Statistics

Revenue (TTM) (Mil) $824.76
EPS (TTM) $ 2.35
Beta1.43
Volatility22.00%
52-Week Range $80.69 - 102.73
Shares Outstanding (Mil)50.29

Analyst Estimate

Dec18 Dec19
Revenue (Mil $) 859 931
EBIT (Mil $) 212 229
EBITDA (Mil $) 234 254
EPS ($) 3.06 3.16
EPS without NRI ($) 3.06 3.16
EPS Growth Rate
(Future 3Y To 5Y Estimate)
18.30%
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 66
Positive ROAY
Positive CFROAY
Higher ROA yoyN
CFROA > ROAN
Lower Leverage yoyY
Higher Current Ratio yoyY
Less Shares Outstanding yoyY
Higher Gross Margin yoyY
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}